| 27 |
Master DAPT After Coronary Artery Stenting |
Sung-Ho Her |
Apr. 17. 25 |
| 26 |
Nagomi Offers Benefits in Complex Lesion |
Shozo Ishihara |
Apr. 17. 25 |
| 25 |
Nagomi Specification and LM Bifurcation |
Hiroaki Matsuda |
Apr. 17. 25 |
| 24 |
Hybrid PCI Strategy: Optimizing Outcomes With Onyx Frontier & Prevail |
Si-Hyuck Kang |
Apr. 17. 25 |
| 23 |
Prevail DCB in Clinical Practice: Case Experiences and Key Learnings From SCAAR |
Muenpetch Muenkaew |
Apr. 17. 25 |
| 22 |
Onyx Frontier in PCI: Expanding Possibilities Through Case-Based Insights |
Hoyun Kim |
Apr. 17. 25 |
| 21 |
The Lower the Better : Rosuvastatin’s Next Option for Dyslipidemia Management |
Doyeon Hwang |
Apr. 17. 25 |
| 20 |
True Atherosclerosis Regression With a 20-Year Legacy, Rosuvastatin |
Jeehoon Kang |
Apr. 17. 25 |
| 19 |
Conquer the Calcium: Safely Break Calcium With ROTAPRO & WOLVERINE |
Dong Oh Kang |
Apr. 17. 25 |
| 18 |
Next-Generation PCI Guidance System: A Closer Look at AVVIGO+ |
Sang Yong Jo |
Apr. 17. 25 |
